Literature DB >> 9129696

Erythema multiforme and toxic epidermal necrolysis: a comparative study.

P Paquet1, G E Piérard.   

Abstract

Erythema multiforme and toxic epidermal necrolysis were considered in the past to be different aspects in the spectrum of a single disease. Using standard histology and immunochemistry we present evidence that the inflammatory infiltrates of erythema multiforme and toxic epidermal necrolysis are strikingly different both in density and nature. Erythema multiforme has a high density cell infiltrate rich in T-lymphocytes. By contrast, toxic epidermal necrolysis is characterized by a cell-poor infiltrate in which macrophages and dendrocytes predominate with a strong immunoreactivity for TNF-alpha. Such differences indicate a distinct pathogenesis for these diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9129696     DOI: 10.1097/00000372-199704000-00005

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  11 in total

Review 1.  A practical guide to diagnose lesser-known immediate and delayed contrast media-induced adverse cutaneous reactions.

Authors:  Ingrid Böhm; Hans H Schild
Journal:  Eur Radiol       Date:  2006-04-20       Impact factor: 5.315

2.  Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.

Authors:  Chuang-Wei Wang; Lan-Yan Yang; Chun-Bing Chen; Hsin-Chun Ho; Shuen-Iu Hung; Chih-Hsun Yang; Chee-Jen Chang; Shih-Chi Su; Rosaline Chung-Yee Hui; See-Wen Chin; Li-Fang Huang; Yang Yu-Wei Lin; Wei-Yang Chang; Wen-Lang Fan; Chin-Yi Yang; Ji-Chen Ho; Ya-Ching Chang; Chun-Wei Lu; Wen-Hung Chung
Journal:  J Clin Invest       Date:  2018-02-05       Impact factor: 14.808

3.  Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017.

Authors:  John R Su; Penina Haber; Carmen S Ng; Paige L Marquez; Graça M Dores; Silvia Perez-Vilar; Maria V Cano
Journal:  Vaccine       Date:  2019-12-20       Impact factor: 3.641

4.  Clinical, etiologic, and histopathologic features of Stevens-Johnson syndrome during an 8-year period at Mayo Clinic.

Authors:  David A Wetter; Michael J Camilleri
Journal:  Mayo Clin Proc       Date:  2010-02       Impact factor: 7.616

5.  Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience.

Authors:  Rachel Forman; Gideon Koren; Neil H Shear
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

6.  Drug-mediated rash: erythema multiforme versus Stevens-Johnson syndrome.

Authors:  Cassandra Hidajat; Duncan Loi
Journal:  BMJ Case Rep       Date:  2014-09-22

Review 7.  Recent progress in herpes simplex virus immunobiology and vaccine research.

Authors:  David M Koelle; Lawrence Corey
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

8.  Acute management of Stevens-Johnson syndrome and toxic epidermal necrolysis to minimize ocular sequelae.

Authors:  Scheffer C G Tseng
Journal:  Am J Ophthalmol       Date:  2009-06       Impact factor: 5.258

Review 9.  Drug induced exfoliative dermatitis: state of the art.

Authors:  Mona-Rita Yacoub; Alvise Berti; Corrado Campochiaro; Enrico Tombetti; Giuseppe Alvise Ramirez; Andrea Nico; Elisabetta Di Leo; Paola Fantini; Maria Grazia Sabbadini; Eustachio Nettis; Giselda Colombo
Journal:  Clin Mol Allergy       Date:  2016-08-22

Review 10.  Review of Toxic Epidermal Necrolysis.

Authors:  Victoria Harris; Christopher Jackson; Alan Cooper
Journal:  Int J Mol Sci       Date:  2016-12-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.